See the DrugPatentWatch profile for Reopro
How much does ReoPro (abciximab) cost?
Pricing for ReoPro is not consistently listed as a standard retail price because it’s typically sold through hospital supply contracts and is administered in an acute, inpatient setting. That means the total cost a patient sees can depend heavily on the hospital, insurance coverage, dosing used for the procedure, and whether it’s billed under drug plus administration charges.
What factors drive the total cost of ReoPro in a hospital?
The final bill is usually affected by:
- The procedure type (e.g., PCI/angioplasty context) and the dosing regimen used.
- Whether the hospital bills separately for the drug, infusion/administration, and related supplies.
- Insurance coverage and the patient’s cost-sharing terms (deductible, coinsurance, copay).
- Country/region and the specific contracting price between the hospital and the supplier.
Is ReoPro still widely used, or are alternatives cheaper?
ReoPro (abciximab) is an older glycoprotein IIb/IIIa inhibitor used in select cardiac catheterization settings. In many markets, newer practice patterns and alternative agents (and protocols) can change which drug is used, which also affects cost and availability—so “ReoPro cost” often depends on what clinicians consider appropriate for the patient’s indication.
How can I get an accurate ReoPro price for my bill?
The fastest way is to use your actual claim details. If you have them, look for:
- The billed line item code for the drug (pharmacy/infusion drug line).
- The date of service and the hospital NPI/provider.
- Your insurance “allowed amount” and your patient responsibility.
If you tell me your country and whether you mean (1) the cash price for the medication or (2) your insurance/hospital bill amount, I can suggest the most direct way to estimate or confirm it.
Sources
I don’t have any provided source links or pricing data for ReoPro in the information available here, so I can’t responsibly quote a specific number.